SFX by Ex Libris Inc.

Title:	The gene encoding phosphodiesterase 4D confers risk of ischemic stroke
Source:	Nature Genetics [1061-4036] Gretarsdottir, Solveig yr:2003

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Gretarsdottir, S. "Erratum: The gene encoding phosphodiesterase 4D confers risk of ischemic stroke (Nature Genetics (2003) 35 (131-138))." Nature Genetics 37.5 (2005): 555-.
description	2.	Stefansson, K. "The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke." Nature genetics 36.3: 233-239.
description	3.	Clowes, A W. "Regulation of smooth muscle cell growth in injured artery." Journal of cardiovascular pharmacology 14 (1989): -15.
description	4.	Helgadottir, A. "A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction." Nature genetics 38.1 (2005): 68-74.
description	5.	O'Brien, E.. "Founder effect: assessment of variation in genetic contributions among founders." Human biology 66.2 (1994): 185-204.
description	6.	Lindner, V. "Factors controlling the development of arterial lesions after injury." Circulation 86.6 Suppl (1992): -6.
description	7.	Munshi, A. "Association of SNP41, SNP56 and a novel SNP in PDE4D gene with stroke and its subtypes." Gene 506.1 (2012): 31-35.
description	8.	Luo, M. "Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity." Proceedings of the National Academy of Sciences of the United States of America 100.21 (2003): 12165-12170.
description	9.	Rifkin, William D D. "Denosumab in postmenopausal women with low bone mineral density." The New England journal of medicine 354.8 (2006): 2390-1.
description	10.	Reilly, A. "A common variant on chromosome 9p21 affects the risk of myocardial infarction." Science 316.5830 (2007): 1491-3.
description	11.	Hakon Hakonarson, H. "Effects of a 5-Lipoxygenase-Activating Protein Inhibitor on Biomarkers Associated With Risk of Myocardial Infarction: A Randomized Trial." JAMA 293.18 (2005): 2245-2256.
description	12.	McPherson, R. "A common allele on chromosome 9 associated with coronary heart disease." Science 316.5830 (2007): 1488-91.
description	13.	Burgett, B. "On the Mormon Question: Race, Sex, and Polygamy in the 1850s and 1990s." American quarterly 57.1 (2005): 75-102.
description	14.	Samani, Nilesh J J. "Genomewide association analysis of coronary artery disease." The New England journal of medicine 357.5 (2007): 443-53.
description	15.	R, Cummings s. "Denosumab for prevention of fractures in postmenopausal women with osteoporosis." New England Journal of Medicine, The 361.8 (2009): 756-765.
description	16.	Miller, Paul D D. "Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial." Bone 43.2 (2008): 222-9.
description	17.	Wassel Fyr, Christina L L. "Genetic admixture, adipocytokines, and adiposity in Black Americans: the Health, Aging, and Body Composition study." Human genetics 121.5 (2007): 615-24.
description	18.	Helgadottir, A. "The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm." Nature genetics 40.2 (2008): 217-24.
description	19.	Reich, D. "A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility." Nature genetics 37.10 (2005): 1113-8.
description	20.	Hauser, E.R. R. "A Genomewide Scan for Early-Onset Coronary Artery Disease in 438 Families: The GENECARD Study." American journal of human genetics 75.3 (2004): 436-447.